Alpha 2.0
Login Register
» Articles » PMID: 28846878

Study on a Novel Polymorphism in the VKORC1 Promoter Region Using Bioinformatic Tools and Warfarin Dosing Data

Overview
Journal Thromb Res
Date 2017 Aug 29
PMID 28846878
Citations 5
Authors
Behnam Askari
Esmat Khaleqsefat
Davood Khalafkhani
Mohammad Khalaj-Kondori
Kamal Khademvatan
Hamid Soraya
Affiliations
Soon will be listed here.
Citing Articles

Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients.

Khaleqsefat E, Rasul K, Kheder R, Baban S, Baban J Sci Rep. 2025; 15(1):288.

PMID: 39747109 PMC: 11695833. DOI: 10.1038/s41598-024-75461-7.

Genetic Polymorphism of Drug Metabolic Gene and of Five Ethnic Minorities in Heilongjiang Province, Northeast China.

Zhang T, Li Q, Dong B, Liang X, Jia M, Bai J Pharmgenomics Pers Med. 2021; 14:1537-1547.

PMID: 34876832 PMC: 8643223. DOI: 10.2147/PGPM.S339854.

The Contribution of and Genetic Polymorphisms and Patients' Demographic Characteristics with Warfarin Maintenance Doses: A Suggested Warfarin Dosing Algorithm.

Khaleqsefat E, Khalaj-Kondori M, Jabarpour Bonyadi M, Soraya H, Askari B Iran J Pharm Res. 2021; 19(3):77-85.

PMID: 33680011 PMC: 7757989. DOI: 10.22037/ijpr.2020.1101116.

Warfarin maintenance dose associated with genetic polymorphisms of CYP2C9.

Khaleqsefat E, Khalaj-Kondori M, Jabbarpour B, Battaloglu E Hippokratia. 2018; 21(2):93-96.

PMID: 30455562 PMC: 6239089.

Optimal nonvitamin K antagonist oral anticoagulant therapy in a warfarin-sensitive patient after left atrial appendage closure: A case report.

Shen L, Fang S, Ge H, Qiao Z, Gu Z Medicine (Baltimore). 2018; 97(18):e0683.

PMID: 29718897 PMC: 6392999. DOI: 10.1097/MD.0000000000010683.